Skaneateles Falls, NY— Welch Allyn, a leading global manufacturer of medical diagnostic equipment and a complete range of digital and connected solutions, announced that Greg Norden and Craig B. Reynolds have been elected by the Welch Allyn shareholders to serve on the Company’s Board of Directors.
Norden and Reynolds join nine incumbent directors, including Chairman of the Board James Crook Jr., Welch Allyn President and CEO Julie Shimer, fourth-generation family members Eric Allyn, Tasha Allyn Given, and Peer Allyn Soderberg, MD, as well as Robert J. Bennett, Larry Buckelew, Yvonne Curl, and Barry Wilson.
“We are very pleased to welcome Greg Norden and Craig Reynolds to our Board of Directors,” said Shimer. “Both bring decades of leadership experience, in-depth knowledge of the healthcare industry, and a common vision for moving Welch Allyn toward even greater growth and success. We look forward to utilizing their know-how and are grateful for their willingnessto share their expertise with Welch Allyn.”
A resident of St. Davids, Pa, Norden brings a proven background in finance and more than 20 years of experience as a senior executive in the global healthcare and pharmaceutical industries. He served as senior vice president and CFO of Wyeth (formerly American Home Products Corp), prior to Pfizer’s acquisition of Wyeth in 2009. Norden had served previously in a series of high level positions at Wyeth and American Home Products, including executive vice president and CFO of Wyeth Pharmaceuticals. Before joining Wyeth, Norden worked in audit management at Arthur Andersen & Co., where he managed major audit engagements for top corporations. Norden is currently a director of Human Genome Sciences, Inc, a leading biopharmaceutical company.
A resident of Kennesaw, Ga, Reynolds has an extensive track record of success in leading top healthcare companies for three decades. He is a former COO and director of Respironics, Inc, a maker of medical devices to diagnose and treat obstructive sleep apnea. When Respironics was acquired by Koninklijke Philips Electronics in 2008, Reynolds served as executive vice president and COO of the Home Healthcare Solutions business of Philips. Before he joined Respironics, Reynolds held various key positions, including CEO and president, during a 17-year career at Healthdyne Technologies Inc., a manufacturer of advanced devices to diagnose and treat medical conditions including sleep and breathing disorders. Reynolds’ leadership experience in the healthcare industry also includes positions at Puritan Bennett Corporation. Having previously served on the Healthdyne Technologies and Respironics Boards, he is now chairman of the Board of Directors of Symmetry Medical, Inc, a provider of implants and related instruments and cases to global orthopedic device manufacturers.
SOURCE: Welch Allyn
